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A one-pot radioiodination of aryl amines via
stable diazonium salts: preparation of 125I-imaging
agents†
Nikki L. Sloan,a Sajinder K. Luthra,b Graeme McRobbie,b Sally L. Pimlottc and
Andrew Sutherland *a
An operationally simple, one-pot, two-step tandem procedure that
allows the incorporation of radioactive iodine into aryl amines via
stable diazonium salts is described. The mild conditions are tolerant
of various functional groups and substitution patterns, allowing late-
stage, rapid access to a wide range of 125I-labelled aryl compounds
and SPECT radiotracers.
The combination of radionuclide labelled molecules and nuclear
imaging techniques has become important for the study of
dynamic biochemical processes at the molecular and cellular
levels.1 The application of these technologies has also extended
into many aspects of medicine and healthcare and include the
diagnosis and prognosis of disease, as well as utilisation in the
drug discovery process, such as understanding drug action and
establishing treatment strategies.2 A key technique within this
field is single-photon emission computed tomography (SPECT)
which, in combination with radioactive tracers, is used for both
preclinical in vitromeasurements (123I/125I) and in vivo diagnostic
imaging (123I).3
Despite the importance of SPECT imaging, one of the limitations
preventing more widespread application of this technique is the
dearth of methods for incorporating radioiodine into small
molecules. In general, SPECT tracers bearing an iodoarene unit
are produced by a substitution reaction using an electrophilic source
of radioactive iodine, prepared under oxidising conditions.3a The
most commonly used approach involves the conversion of aryl
halides into the corresponding organostannane via palladium(0)
catalysis, followed by an oxidative iodo-destannylation reaction
(Fig. 1a).2,3a While this method generates SPECT imaging agents
with high specific activity and radiochemical purity,4 there are
obvious toxicity risks associated with the generation of clinical
tracers from organotin compounds. In addition, the unstable
nature of organotin compounds prevents long-term storage and
can result in unreliable radioiodination.5 Although there are
significant issues associated with this approach, there have been
relatively few reports of new methods for the radioiodination of
aryl compounds.6 In 2013, we reported a nickel(0)-catalysed
radioiodination of aryl and heteroaryl bromides (Fig. 1b).7 While
fast and efficient, this method requires elevated temperatures
(180 1C) for complete conversion. More recently, the groups of
Gouverneur and Zhang described the copper-mediated radio-
iodination of aryl boronic acids and esters (Fig. 1c).8–11 Besides
showing a broad substrate scope, these methods were used for
the preparation of various SPECT imaging agents.8,9
We were interested in developing a new general method for
the radioiodination of aryl compounds with the criteria of
Fig. 1 Methods for radioiodination of arenes.
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using widely available starting materials and mild reaction
conditions. The preparation of diazonium salts from aryl amines
followed by a Sandmeyer-type reaction is a common approach for
the preparation of aryl iodides.12 However, previous attempts to
use this two-step transformation for radioiodination were largely
abandoned.13 The harsh acidic conditions required for the
formation of diazonium salts and their unstable, potentially
explosive nature led to unwanted by-products and low radio-
chemical yields. Here we report an operationally simple, one-pot
radioiodination of aryl amines that overcomes these previous
limitations. Formation of the diazonium salts under mild con-
ditions, using a polymer-supported nitrite reagent and p-toluene-
sulfonic acid (p-TsOH) as the proton source, followed by direct
radioiodination, has produced labelled products in high radio-
chemical yields (Fig. 1d). Application of this new strategy for the
preparation of various SPECT imaging agents is also described.
A number of groups have shown that the key limitations
associated with the standard conditions of diazonium salt
formation, such as the use of strong acids and sodium nitrite,
which can lead to the release of nitrogen oxides, can be avoided
using a polymer-supported nitrite reagent.14 These are simply
prepared by the ion exchange of tetraalkylammonium functionalised
resins, such as Amberlyst A-26, using an aqueous solution of sodium
nitrite. Filimonov and co-workers have combined the use of a
polymer-supported nitrite with mild acidic conditions ( p-TsOH)
and showed that the resulting tosylate diazonium salts were
thermally stable and could be used for the stepwise preparation
of aryl iodides under aqueous conditions.14c,d These advances
served as a starting point for the development of our rapid, one-
pot tandem radioiodination of aryl amines.
Our initial studies focused on the development of a mild,
one-pot diazotisation–iodination of aryl amines that would also
be amenable for radioiodination. Preliminary optimisation
studies with 4-nitroaniline (1a) showed that when using acetonitrile
as the solvent, all the reagents (polymer-supported nitrite, p-TsOH
and sodium iodide) could be added together, resulting in a fast and
efficient tandem conversion to the corresponding iodide, 2a
(86% yield). These conditions were then investigated for the
radioiodination of 4-nitroaniline (1a), where the radiochemical
yields (RCY) were determined by radio-HPLC analysis of the
crude product.15 Using [125I]NaI (4–6 MBq solution in water) as
the limiting reagent and three equivalents of both the polymer-
supported nitrite reagent and p-TsOH gave a low RCY (Table 1,
entry 1). The concentration of 1a in the reaction mixture was
then varied and using more dilute conditions, which allowed
better mixing of reagents, resulted in a dramatic increase in the
RCY of 2a. In particular, a concentration of 0.018 mol L1 of 1a
(0.5 mg of 1a in 200 mL of solvent) gave an excellent RCY of 93%
(entry 3). The corresponding radio-HPLC chromatogram for this
reaction showed a particularly clean transformation with no
other radiolabelled side-products (Fig. 2). Other variables of the
one-pot tandem process were also investigated such as reaction
temperature and the number of equivalents of reagents (entries
4–8). Higher temperatures led to a drop in the RCY due to the
formation of 4-nitrophenol as a side-product, while higher
quantities of reagents again led to inefficient mixing of the
small-scale reaction and a lower RCY. Although a high RCY was
achieved using one equivalent of both reagents (entry 7), the
conditions used in entry 3 were deemed optimal for radioiodination.
The optimised radioiodination conditions were evaluated
for the preparation of a range of 125I-labelled aryl compounds
(Scheme 1). Under these standard conditions, electron-deficient
and electron-rich compounds (1a–1h) with various substitution
patterns were found to be compatible and converted to 125I-iodinated
compounds in excellent RCYs. Only two substrates required further
optimisation. The highest RCY of 97% for 4-[125I]iodoanisole (2c) was
achieved when the one-pot tandem process was conducted at
40 1C, while a four-hour reaction gave the best RCY (94%) for
2-[125I]iodobenzophenone (2e).
Having demonstrated the general scope of the one-pot
tandem diazotisation–radioiodination process on simple arenes,
the next stage of this work was to show that it could also be
applied to the synthesis of more complex biologically active aryl
iodides and SPECT radiotracers (2i–2m, Scheme 1).16 Again,
using [125I]NaI as the limiting reagent under dilute conditions,
it was found that an increase in the amount of both the polymer-
supported nitrite and p-TsOH (to six equivalents) was required to
achieve good yields for a two-hour reaction. Further optimisation
showed that a higher reaction temperature (60 1C) gave improved
Table 1 Optimisation of the one-pot diazotisation–radioiodination of 4-
nitroaniline (1a)a
Entry Conc. of 1a (mol L1) Eq. of reagentsb Temp. (1C) RCY (%)
1 0.18 3 20 4
2 0.07 3 20 44
3 0.018 3 20 93
4 0.009 3 20 80
5 0.018 3 40 65
6 0.018 3 60 54
7 0.018 1 20 82
8 0.018 6 20 43
a All reactions were performed using a 4–6 MBq solution of [125I]NaI in
water (0.01 mL). b Polymer-supported nitrite and p-TsOH.
Fig. 2 Chromatogram obtained by analytical radio-HPLC of the reaction
mixture from the radioiodination of 4-nitroaniline (1a), showing a 93% yield
of radioiodide incorporation.
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RCYs for some of the substrates. Overall, the one-pot transformation
was effective for all the targets, leading to a new radiosynthesis of
the well-established imaging agents iomazenil (2i),17 a SPECT tracer
of central-type benzodiazepine receptors in brain tissue; CNS1261
(2j),18 a radioligand of the N-methyl-D-aspartate (NMDA) receptor;
and IBOX (2k), a SPECT imaging agent of amyloid plagues.19 The
best result was achieved for [125I]iomazenil (2i), with a particularly
clean reaction and a RCY of 92%. This is higher than that for the
reported oxidative iodo-destannylation of a tri-n-butylstannane
precursor (70%), which was complicated by the formation of
non-radioactive reduced and halogenated by-products.20 The
synthesis of [125I]iomazenil (2i) was also found to be highly
reproducible, with a RCY of 89  8% (n = 9). This study has also
allowed the first preparation of a radioiodinated version of
quinoline-2-carboxamide 2l, a high-affinity agent (Ki 5 nM) for
the translocator protein (TSPO), a membrane protein that is
overexpressed during chronic neurodegeneration or acute brain
injury.21 As the radiosynthesis of this compound is now developed,
the full potential of this tracer can be explored as a potential
SPECT imaging agent of neuroinflammation processes associated
with TSPO. The one-pot diazotisation–radioiodination was also
effective for the preparation of phthalazinone 2m, which is a
nanomolar inhibitor (IC50 7 nM), and a SPECT imaging agent of
poly(ADP-ribose) polymerase-1 (PARP-1), a therapeutic target for
the treatment of cancer.22 The previous 125I-labelled synthesis of
2m was achieved by solid-state halogen exchange using a
bromide precursor. Although this did give a 90% RCY, a reaction
temperature of 210 1C was required.
Besides using widely available starting materials, avoiding
highly toxic reagents and harsh conditions, it should be emphasised
that other advantages of this one-pot diazotisation–radioiodination
process are a very simple work-up procedure and isolation protocol.
Following completion of the reaction, the radioactive mixture is
filtered to remove the polymer-supported nitrite, diluted and
purified, directly by HPLC to yield the 125I-labelled compounds.
These advantages were exemplified with the validation of the
one-pot method for the synthesis and purification of [125I]iomazenil
(2i). The amine precursor 1i was treated with [125I]NaI (4–6 MBq),
polymer-supported nitrite and p-TsOH at 60 1C for 2 hours
(Scheme 2). After HPLC purification, [125I]iomazenil (2i) was
isolated in 75 10% radioactivity yield. The radiochemical purity
of 2i was measured to be499%, with a molar activity of 16.2 
1.22 GBq mmol1. As with all reactions, identification of the
product was confirmed using HPLC, demonstrating co-elution
with a sample of unlabelled iomazenil.
In summary, an operationally simple, one-pot, two-step
tandem process for the preparation of radioiodine containing
arenes from readily available anilines has been developed. The
use of mild conditions for diazonium salt formation resulted in
a process with a broad scope that is tolerant of a wide range of
functional groups and substitution patterns. In particular, this
process allowed the preparation of a range of important SPECT
imaging agents, including [125I]iomazenil, [125I]CNS1261 and
[125I]IBOX, as well as the first radiosynthesis of a high affinity
agent of TSPO, which can now be used to study neuroinflammation.
Current studies are investigating the application of this method for
the development of novel SPECT imaging agents and the use of
solid-phase extraction for more simple and rapid purification.
Financial support from Medical Research Scotland (student-
ship to N. L. S.), GE Healthcare Ltd and the University of
Glasgow is gratefully acknowledged.
Scheme 1 Scope of one-pot diazotisation–radioiodination. a Reaction
was performed at 40 1C. b Reaction required 4 h. c Reaction was
performed at 60 1C.
Scheme 2 Radiosynthesis of [125I]iomazenil (2i).
ChemComm Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
A
ug
us
t 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
6/
10
/2
01
7 
11
:5
1:
51
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2017 Chem. Commun., 2017, 53, 11008--11011 | 11011
Conflicts of interest
There are no conflicts to declare.
Notes and references
1 (a) S. M. Ametamey, M. Honer and P. A. Schubiger, Chem. Rev., 2008,
108, 1501; (b) P. W. Miller, N. J. Long, R. Vilar and A. D. Gee, Angew.
Chem., Int. Ed., 2008, 47, 8998; (c) S. Preshlock, M. Tredwell and
V. Gouverneur, Chem. Rev., 2016, 116, 719.
2 (a) M. J. Adam and D. S. Wilbur, Chem. Soc. Rev., 2005, 34, 153;
(b) A. Signore, S. J. Mather, G. Piaggio, G. Malviya and R. A. Dierckx,
Chem. Rev., 2010, 110, 3112; (c) S. L. Pimlott and A. Sutherland,
Chem. Soc. Rev., 2011, 40, 149.
3 (a) R. H. Seevers and R. E. Counsell, Chem. Rev., 1982, 82, 575;
(b) M. M. Khalil, J. L. Tremoleda, T. B. Bayomy and W. Gsell, Int.
J. Mol. Imaging, 2011, 2011, 796025.
4 For example: S. L. Pimlott, L. Stevenson, D. J. Wyper and A. Sutherland,
Nucl. Med. Biol., 2008, 35, 537.
5 For example: A. G. Horti, A. O. Koren, K. S. Lee, A. G.Mukhin, D. B. Vaupel,
A. S. Kimes, M. Stratton and E. D. London, Nucl. Med. Biol., 1999, 26, 175.
6 (a) N. L. Sloan and A. Sutherland, Synthesis, 2016, 2969; (b) D. T. Racys,
S. A. I. Sharif, S. L. Pimlott and A. Sutherland, J. Org. Chem., 2016, 81, 772.
7 A. A. Cant, S. Champion, R. Bhalla, S. L. Pimlott and A. Sutherland,
Angew. Chem., Int. Ed., 2013, 52, 7829.
8 T. C. Wilson, G. McSweeney, S. Preshlock, S. Verhoog, M. Tredwell,
T. Cailly and V. Gouverneur, Chem. Commun., 2016, 52, 13277.
9 P. Zhang, R. Zhuang, Z. Guo, X. Su, X. Chen and X. Zhang, Chem. –
Eur. J., 2016, 22, 16783.
10 Radioiodination of boron derived arenes using chloramine-T has also
been reported: (a) P. C. Srivastava, A. P. Callahan, E. B. Cunningham and
F. F. Knapp, J. Med. Chem., 1983, 26, 742; (b) L. Yong, M.-L. Yao,
J. F. Green, H. Kelly and G. W. Kabalka, Chem. Commun., 2010, 46, 2623.
11 A copper mediated non-radioactive iodination of aryl boronate
esters using iodide as the limiting reagent has been reported:
B. M. Partridge and J. F. Hartwig, Org. Lett., 2013, 15, 140.
12 (a) T. Sandmeyer, Ber. Dtsch. Chem. Ges., 1884, 17, 1633; (b) H. H. Hodgson,
Chem. Rev., 1947, 40, 251; (c) C. Gali, Chem. Rev., 1988, 88, 765.
13 (a) G.-J. Meyer, K. Ro¨ssler and G. Sto¨cklin, J. Am. Chem. Soc., 1979,
101, 3121; (b) S. M. Moerlein, C. A. Mathis and Y. Yano, J. Labelled
Compd. Radiopharm., 1986, 33, 1237; (c) D. S. Wilbur, Bioconjugate
Chem., 1992, 3, 433.
14 (a) M. Caldarelli, I. R. Baxendale and S. V. Ley, Green Chem., 2000, 2, 43;
(b) J. Merrington, M. James and M. Bradley, Chem. Commun., 2002, 140;
(c) V. D. Filimonov, M. Trusova, P. Postnikov, E. A. Krasnokutskaya,
Y. M. Lee, H. Y. Hwang, H. Kim and K.-W. Chi,Org. Lett., 2008, 10, 3961;
(d) M. E. Trusova, E. A. Krasnokutskaya, P. S. Postnikov, Y. Choi,
K.-W. Chi and V. D. Filimonov, Synthesis, 2011, 2154.
15 The radiochemistry nomenclature used in this paper is in accordance
with the new guidelines recommended by the Society of Radiopharma-
ceutical Sciences. See: http://www.srsweb.org/nomenclature-guidelines
and: P. H. Elsinga, EJNMMI Radiopharmacy and Chemistry, 2017, 2, 2.
16 See the ESI† for full details on the synthesis of each amine precursor.
17 For example: (a) S. S. Zoghbi, R. M. Baldwin, J. P. Seibyl, M. S. Al-Tikriti,
Y. Zea-Ponce, M. Laruelle, E. H. Sybirska, S. W. Woods, A. W. Goddard,
R. T. Malison, R. Zimmerman, D. S. Charney, E. O. Smith, P. B. Hoffer
and R. B. Innis, Nucl. Med. Biol., 1992, 19, 881; (b) K. Mori, T. Mori,
Y. Toda, E. Fujii, M. Miyazaki, M. Harada and S. Kagami, Brain Dev.,
2012, 34, 478.
18 (a) J. Owens, A. A. Tebbutt, A. L. McGregor, K. Kodama, S. S. Magar,
M. E. Perlman, D. J. Robins, G. J. Durant and J. McCulloch, Nucl.
Med. Biol., 2000, 27, 557; (b) R. J. J. Knol, K. De Bruin, B. L. F. Van
Eck-Smit, S. Pimlott, D. J. Wyper and J. Booij, Synapse, 2009, 67,
557.
19 Z.-P. Zhuang, M.-P. Kung, C. Hou, K. Plo¨ssl, D. Skovronsky,
T. L. Gur, J. Q. Trojanowski, V. M.-Y. Lee and H. F. Kung, Nucl.
Med. Biol., 2001, 28, 887.
20 B. J. McBride, R. M. Baldwin, J. M. Kerr and J.-L. Wu, Appl. Radiat.
Isot., 1991, 42, 173.
21 A. Blair, L. Stevenson, D. Dewar, S. L. Pimlott and A. Sutherland,
MedChemComm, 2013, 4, 1461.
22 F. Zmuda, G. Malviya, A. Blair, M. Boyd, A. J. Chalmers,
A. Sutherland and S. L. Pimlott, J. Med. Chem., 2015, 58, 8683.
Communication ChemComm
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
A
ug
us
t 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
6/
10
/2
01
7 
11
:5
1:
51
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
